FantasticSearch

Scroll to: TopResults

Explore European Union Legislation by Asking a Legal Question

assisted-checkbox

filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all

parameters-title

query

assisted-checkbox:

result-title

total 6

Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_I

CELEX:  31997R0467

Additional INNs to receive duty-free treatment CN code CAS RN Name 2844 40 30 113716-48-6 Iolopride (123 I) 142481-95-6 Technetium (99m Tc) furifosmin 2846 90 00 131069-91-5 Gadoversetamide 135326-11-3 Gadoxetic acid 138721-73-0 Sprodiamide 2914 40 90 20098-14-0 Idramantone 2916 39 00 71109-09-6 Vedaprofen 2918 30 00 22161-81-5 Dexketoprofen 112665-43-7 Seratrodast 2918 90 90 139403-31-9 Pimilprost 2921 49 90 136236-51-6 Rasagiline 2922 49 70 6582-31-6 Dapabutan 2923 90 00 1794-75-8 Laurcetium bromide 2924 10 00 1675-66-7 Adelmidrol 62304-98-7 Thymalfasin 132787-19-0 Tradecamide 129009-83-2 Versetamide 2924 29 90 147362-57-0 Loviride 94497-51-5 Tamibarotene 2925 19 80 144849-63-8 Bisnafide 2925 20 00 137159-92-3 Aptiganel 2926 90 80 137109-71-8 Balazipone 147076-36-6 Laflunimus 2928 00 90 141579-54-6 Fenleuton 2930 90 16 87573-01-1 Salnacedin 2930 90 70 90357-06-5 Bicalutamide 112573-72-5 Dexecadotril 107023-41-6 Pobilukast 81110-73-8 Racecadotril 2931 00 50 132236-18-1 Zifrosilone 2931 00 80 114084-78-5 Ibandronic acid 124351-85-5 Incadronic acid 63132-39-8 Olpadronic acid 2932 99 70 105674-77-9 Lanproston 2932 99 90
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_I

CELEX:  31997R0467

123407-36-3 Arteflene 132017-01-7 Bervastatin 110816-79-0 Cromoglicate lisetil 149494-37-1 Ebalzotan 151581-24-7 Iralukast 113806-05-6 Olopatadine 139110-80-8 Zanamivir 2933 29 90 158682-68-9 Elisartan 116684-92-5 Galdansetron 89371-44-8 Imidaprilat 138402-11-6 Irbesartan 118072-93-8 Zoledronic acid 2933 39 95 119257-34-0 Besipirdine 118248-91-2 Fodipir 155415-08-0 Inogatran 121750-57-0 Itameline 144412-49-7 Lamifiban 155319-91-8 Mangafodipir 150443-71-3 Nicanartine 29876-14-0 Nicotredole 144035-83-6 Piclamilast 137795-35-8 Spiroglumide 147025-53-4 Talsaclidine 149488-17-5 Trovirdine 2933 40 10 127294-70-6 Balofloxacin 143383-65-7 Premafloxacin 143224-34-4 Telinavir 2933 40 90 96946-42-8 Cisatracurium besilate 158966-92-8 Montelukast 136668-42-3 Quiflapon 2933 59 70 127266-56-2 Adatanserin 106941-25-7 Adefovir 113852-37-2 Cidofovir 150756-35-7 Efletirizine 119687-33-1 Iganidipine 127759-89-1 Lobucavir 140945-32-0 Mapinastine 134208-17-6 Mazapertine 96604-21-6 Ocinaplon 148504-51-2 Ripisartan 115762-17-9 Ruzadolane 118420-47-6 Tagorizine 137234-62-9 Voriconazole 151319-34-5 Zaleplon 2933 79 00 148396-36-5 Fradafiban 74436-00-3 Geclosporin
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_I

CELEX:  31997R0467

143943-73-1 Lirequinil 106730-54-5 Olprinone 135548-15-1 Oxeclosporin 145733-36-4 Tasosartan 143343-83-3 Toborinone 2933 90 95 137882-98-5 Abitesartan 114607-46-4 Acitazanolast 120511-73-1 Anastrozole 134523-00-5 Atorvastatin 128270-60-0 Bivalirudin 139481-59-7 Candesartan 54278-85-2 Candocuronium iodide 105806-65-3 Efegatran 62568-57-4 Emideltide 120081-14-3 Goralatide 142880-36-2 Ilornastat 62732-44-9 Ipidacrine 116287-14-0 Lanperisone 112809-51-5 Letrozole 116644-53-2 Mibefradil 136122-46-8 Mipitroban 144702-17-0 Pomisartan 132036-88-5 Ramosetron 106308-44-5 Rufinamide 144701-48-4 Telmisartan 147059-72-1 Trovafloxacin 2934 10 00 149079-51-6 Cartasteine 128312-51-6 Cinalukast 51287-57-1 Denotivir 101001-34-7 Pamicogrel 136433-51-7 Tazofelone 138742-43-5 Zankiren 2934 20 90 144665-07-6 Lubeluzole 150915-41-6 Perospirone 146939-27-7 Ziprasidone 2934 90 60 130370-60-4 Batimastat 133040-01-4 Eprosartan 135202-79-8 Ilonidap 114686-12-3 Imitrodast 132418-36-1 Rocepafant 132418-35-0 Setipafant 2934 90 70 125533-88-2 Mofarotene 127045-41-4 Pazufloxacin 2934 90 80 118292-40-3 Tazarotene 2934 90 98 151356-08-0 Afovirsen 138298-79-0 Alnespirone
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_I

CELEX:  31997R0467

152317-89-0 Alniditan 153420-96-3 Atibeprone 143393-27-5 Azalanstat 149908-53-2 Azimilide 150490-85-0 Berupipam 154361-50-9 Capecitabine 133099-04-4 Darifenacin 137500-42-6 Darsidomine 114030-44-3 Dexpemedolac 115464-77-2 Elopiprazole 141790-23-0 Fozivudine tidoxil 122254-45-9 Glenvastatin 143443-90-7 Ifetroban 82857-82-7 Ilepcimide 104454-71-9 Ipenoxazone 118288-08-7 Lafutidine 138068-37-8 Lepirudin 78994-23-7 Levormeloxifene 116476-16-5 Levosemotiadil 148152-63-0 Napitane 84558-93-0 Netivudine 147432-77-7 Ontazolast 139225-22-2 Panamesine 103255-66-9 Pazinaclone 123447-62-1 Prulifloxacin 131986-45-3 Xanomeline 145781-32-4 Zolasartan 2935 00 90 147536-97-8 Bosentan 136817-59-9 Delavirdine 119905-05-4 Delequamine 112966-96-8 Domitroban 125279-79-0 Ersentilide 139133-26-9 Lexipafant 154397-77-0 Napsagatran 139133-27-0 Nupafant 116649-85-5 Ramatroban 133276-80-9 Samixogrel 146623-69-0 Saprisartan 149556-49-0 Susalimod 144494-65-5 Tirofiban 139308-65-9 Tolafentrine 107753-78-6 Zafirlukast 2936 29 90 131875-08-6 Lexacalcitol 2937 10 10 9002-68-0 Follitropin alfa 152923-57-4 Lutropin alfa 2937 22 00 103466-73-5 Icometasone enbutate 2937 29 90 144459-70-1
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_I

CELEX:  31997R0467

Rofleponide 2937 99 00 124478-60-0 Aglepristone 140703-51-1 Examorelin 133107-64-9 Insulin lispro 144743-92-0 Teverelix 2939 50 90 151581-23-6 Apaxifylline 132210-43-6 Cipamfylline 100324-81-0 Lisofylline 98833-92-2 Stacofylline 2939 90 90 135905-89-4 Mirisetron 117086-68-7 Ricasetron 25775-90-0 Zucapsaicin 2940 00 90 133692-55-4 Seprilose 2941 90 00 127785-64-2 Basifungin 116853-25-9 Cefluprenam 122841-10-5 Cefoselis 156131-91-8 Dimadectin 123997-26-2 Eprinomectin 149951-16-6 Lenapenem 108852-90-0 Nemorubicin 159445-62-2 Orientiparcin 156769-21-0 Sanfetrinem 3001 90 99 120993-53-5 Desirudin 3002 10 91 143653-53-6 Abciximab 156227-98-4 Afelimomab 151763-64-3 Capromab 152923-56-3 Dacliximab 145832-33-3 Detumomab 142864-19-5 Enlimomab 152981-31-2 Inolimomab 150631-27-9 Nacolomab tafenatox 159445-64-4 Odulimomab 147191-91-1 Priliximab 153101-26-9 Regavirumab 148189-70-2 Votumumab 3002 10 95 143090-92-0 Anakinra 143631-61-2 Atexakin alfa 148637-05-2 Cilmostim 154725-65-2 Epoetin epsilon 148363-16-0 Epoetin omega 102786-52-7 Eptacog alfa (activated) 156679-34-4 Lenercept 124146-64-1 Mobenakin 0-00-0 Moroctocog alfa 148641-02-5 Muplestim
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_I

CELEX:  31997R0467

139076-62-3 Octocog alfa 3003 39 00 0-00-0 Plusonermin 3003 90 90 0-00-0 Fuladectin 3507 90 90 143831-71-4 Dornase alfa 154248-97-2 Imiglucerase 149394-67-2 Ledimase 156616-23-8 Monteplase 159445-63-3 Nateplase 155773-57-2 Pegorgotein 3911 90 19 95522-45-5 Colestilan 31512-74-0 Polixetonium chloride 3913 90 80 39464-87-4 Betasizofiran 0-00-0 Certoparin sodium 0-00-0 Minolteparin sodium